相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
Robbert G. van der Most et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy
Steve A. Broomfield et al.
JOURNAL OF IMMUNOLOGY (2009)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
Joseph D. Miller et al.
IMMUNITY (2008)
Targeting the effector site with IFN-αβ-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors
Andrew J. Currie et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficient tumour formation by single human melanoma cells
Elsa Quintana et al.
NATURE (2008)
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
Ailsa J. Frew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
Kazuyoshi Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all
R. G. van der Most et al.
CELL DEATH AND DIFFERENTIATION (2008)
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Larisa L. Belyanskaya et al.
MOLECULAR CANCER (2007)
Gemcitabine as significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects
Eiji Suzuki et al.
CANCER BIOLOGY & THERAPY (2007)
Cancer: Novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway
Erika Cretney et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Efficient T cell activation via a Toll-interleukin 1 Receptor-independent pathway
Edith Janssen et al.
IMMUNITY (2006)
Importance of signaling via the IFN-α/β receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor
MB Mokyr et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Chemoimmunotherapy of tumors:: Cyclophosphamide synergizes with exosome based vaccines
Julien Taieb et al.
JOURNAL OF IMMUNOLOGY (2006)
NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors
ZS Fan et al.
BLOOD (2006)
Cranking the immunologic engine with chemotherapy: Using context to drive tumor antigen cross-presentation towards useful antitumor immunity
RG van der Most et al.
CANCER RESEARCH (2006)
Eradication of established tumors in mice by a combination antibody-based therapy
Tomoyasu Uno et al.
NATURE MEDICINE (2006)
Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
TJ Sayers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection
GA Kolumam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response
AM Ercolini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis
AD Brooks et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Mesothelin-specific CD8+ T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients
AM Thomas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Cutting edge: Tumor-specific CTL are constitutively cross-armed in draining lymph nodes and transiently disseminate to mediate tumor regression following systemic CD40 activation
PA Stumbles et al.
JOURNAL OF IMMUNOLOGY (2004)
IFN-γ enhances TRAIL-induced apoptosis through IRF-1
SY Park et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
A Le Bon et al.
NATURE IMMUNOLOGY (2003)
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
AK Nowak et al.
JOURNAL OF IMMUNOLOGY (2003)
Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation
M Shigeno et al.
ONCOGENE (2003)
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor rejection by disturbing tumor stroma cell interactions
S Ibe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Melphalan-induced expression of IFN-β in MOPC-315 tumor-bearing mice and its importance for the up-regulation of TNF-α expression
VM Jovasevic et al.
JOURNAL OF IMMUNOLOGY (2001)
Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines
WH Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism
B Peláez et al.
JOURNAL OF IMMUNOLOGY (2001)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans
LE Harrington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
